Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

David S. Ettinger; Douglas E. Wood; Charu Aggarwal; Dara L. Aisner; Wallace Akerley; Jessica R. Bauman; Ankit Bharat; Debora S. Bruno; Joe Y. Chang; Lucian R. Chirieac; Thomas A. D'Amico; Thomas J. Dilling; Michael Dobelbower; Scott Gettinger; Ramaswamy Govindan; Matthew A. Gubens; Mark Hennon; Leora Horn; Rudy P. Lackner; Michael Lanuti; Ticiana A. Leal; Jules Lin; Billy W. Loo; Renato G. Martins; Gregory A. Otterson; Sandip P. Patel; Karen L. Reckamp; Gregory J. Riely; Steven E. Schild; Theresa A. Shapiro; James Stevenson; Scott J. Swanson; Kurt W. Tauer; Stephen C. Yang; Kristina Gregory; Miranda Hughes

doi:10.6004/jnccn.2019.0059

Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Thomas J. Dilling, Michael Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael LanutiTiciana A. Leal, Jules Lin, Billy W. Loo, Renato G. Martins, Gregory A. Otterson, Sandip P. Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina Gregory, Miranda Hughes

Surgery, Thoracic Surgery Division

Research output: Contribution to journal › Article › peer-review

618 Scopus citations

Abstract

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances".

Original language	English (US)
Pages (from-to)	1464-1472
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2019.0059
State	Published - 2019

Funding

This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Clovis Oncology, Eisai, Genentech, Genomic Health, Inc., Novartis, Taiho Oncology, Inc., and TESARO. This activity is supported by an independent educational grant from AbbVie. This activity is supported by educational funding provided by Amgen. This activity is supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs. In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2019.0059

Cite this

Ettinger, D. S., Wood, D. E., Aggarwal, C., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., Dobelbower, M., Gettinger, S., Govindan, R., Gubens, M. A., Hennon, M., Horn, L., Lackner, R. P., ... Hughes, M. (2019). Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 17(12), 1464-1472. https://doi.org/10.6004/jnccn.2019.0059

@article{f3cf7f02de2744d3b7b73945b58d7ee7,

title = "Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as {"}preferred interventions,{"} whereas others are categorized as either {"}other recommended interventions{"} or {"}useful under certain circumstances{"}.",

author = "Ettinger, \{David S.\} and Wood, \{Douglas E.\} and Charu Aggarwal and Aisner, \{Dara L.\} and Wallace Akerley and Bauman, \{Jessica R.\} and Ankit Bharat and Bruno, \{Debora S.\} and Chang, \{Joe Y.\} and Chirieac, \{Lucian R.\} and D'Amico, \{Thomas A.\} and Dilling, \{Thomas J.\} and Michael Dobelbower and Scott Gettinger and Ramaswamy Govindan and Gubens, \{Matthew A.\} and Mark Hennon and Leora Horn and Lackner, \{Rudy P.\} and Michael Lanuti and Leal, \{Ticiana A.\} and Jules Lin and Loo, \{Billy W.\} and Martins, \{Renato G.\} and Otterson, \{Gregory A.\} and Patel, \{Sandip P.\} and Reckamp, \{Karen L.\} and Riely, \{Gregory J.\} and Schild, \{Steven E.\} and Shapiro, \{Theresa A.\} and James Stevenson and Swanson, \{Scott J.\} and Tauer, \{Kurt W.\} and Yang, \{Stephen C.\} and Kristina Gregory and Miranda Hughes",

note = "Publisher Copyright: {\textcopyright} 2019 JNCCN - Journal of the National Comprehensive Cancer Network.",

year = "2019",

doi = "10.6004/jnccn.2019.0059",

language = "English (US)",

volume = "17",

pages = "1464--1472",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "12",

}

Ettinger, DS, Wood, DE, Aggarwal, C, Aisner, DL, Akerley, W, Bauman, JR, Bharat, A, Bruno, DS, Chang, JY, Chirieac, LR, D'Amico, TA, Dilling, TJ, Dobelbower, M, Gettinger, S, Govindan, R, Gubens, MA, Hennon, M, Horn, L, Lackner, RP, Lanuti, M, Leal, TA, Lin, J, Loo, BW, Martins, RG, Otterson, GA, Patel, SP, Reckamp, KL, Riely, GJ, Schild, SE, Shapiro, TA, Stevenson, J, Swanson, SJ, Tauer, KW, Yang, SC, Gregory, K & Hughes, M 2019, 'Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 12, pp. 1464-1472. https://doi.org/10.6004/jnccn.2019.0059

TY - JOUR

T1 - Non-small cell lung cancer, version 1.2020

T2 - Featured updates to the NCCN guidelines

AU - Ettinger, David S.

AU - Wood, Douglas E.

AU - Aggarwal, Charu

AU - Aisner, Dara L.

AU - Akerley, Wallace

AU - Bauman, Jessica R.

AU - Bharat, Ankit

AU - Bruno, Debora S.

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Dilling, Thomas J.

AU - Dobelbower, Michael

AU - Gettinger, Scott

AU - Govindan, Ramaswamy

AU - Gubens, Matthew A.

AU - Hennon, Mark

AU - Horn, Leora

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Leal, Ticiana A.

AU - Lin, Jules

AU - Loo, Billy W.

AU - Martins, Renato G.

AU - Otterson, Gregory A.

AU - Patel, Sandip P.

AU - Reckamp, Karen L.

AU - Riely, Gregory J.

AU - Schild, Steven E.

AU - Shapiro, Theresa A.

AU - Stevenson, James

AU - Swanson, Scott J.

AU - Tauer, Kurt W.

AU - Yang, Stephen C.

AU - Gregory, Kristina

AU - Hughes, Miranda

PY - 2019

Y1 - 2019

N2 - The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances".

AB - The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances".

UR - https://www.scopus.com/pages/publications/85077110186

UR - https://www.scopus.com/inward/citedby.url?scp=85077110186&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0059

DO - 10.6004/jnccn.2019.0059

M3 - Article

C2 - 31805526

AN - SCOPUS:85077110186

SN - 1540-1405

VL - 17

SP - 1464

EP - 1472

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 12

ER -

Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this